Orexin receptor antagonists and insomnia treatment: state of the art

被引：0
|
作者：
Gotter, A. L. [1 ]
Coleman, P. J. [2 ]
Kuduk, S. D. [2 ]
Tannenbaum, P. L. [1 ]
Struyk, A. [3 ]
Wrishko, R. E. [4 ]
Connor, K. M. [5 ]
Herring, W. J. [5 ]
Renger, J. J. [1 ]
Winrow, C. J. [1 ]
机构：
[1] Merck Res Labs, Dept Neurosci, West Point, PA USA
[2] Merck Res Labs, Dept Med Chem, West Point, PA USA
[3] Merck Res Labs, Dept Clin Pharmacol & Expt Therapeut, West Point, PA USA
[4] Merck Res Labs, Dept Pharmacokinet & Drug Metab, West Point, PA USA
[5] Merck Res Labs, Dept Clin Res, West Point, PA USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2014年 / 24卷
关键词：
D O I：
10.1016/S0924-977X(14)70211-1
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S.27.02
引用
收藏
页码：S144 / S145
页数：2
相关论文
共 50 条
  • [41] Innovations in Insomnia Management: A Review of Current Approaches and Novel Targets Including Orexin Receptor Antagonists
    Patel, Raj
    Quinn, Ryann
    Silver, Jonathan
    AMERICAN JOURNAL OF THERAPEUTICS, 2018, 25 (01) : E28 - E35
  • [42] Orexin receptor antagonism for treatment of insomnia A randomized clinical trial of suvorexant
    Herring, W. Joseph
    Snyder, Ellen
    Budd, Kerry
    Hutzelmann, Jill
    Snavely, Duane
    Liu, Kenneth
    Lines, Christopher
    Roth, Thomas
    Michelson, David
    NEUROLOGY, 2012, 79 (23) : 2265 - 2274
  • [43] Comparison of efficacy and safety of dual orexin receptor antagonists lemborexant and daridorexant for the treatment of insomnia: a systematic review and meta-analysis
    Tang, Ming
    Shen, Ziyi
    Yu, Peilu
    Yu, Meiling
    Tong, Xiaoqiong
    Jiang, Guohui
    PSYCHOPHARMACOLOGY, 2025,
  • [44] GPCR structure-based drug discovery: Identification of dual orexin antagonists and orexin-1 selective antagonists for the treatment of insomnia and addiction disorders
    Christopher, John A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
  • [45] PHARMACOLOGICAL CHARACTERIZATION OF OREXIN RECEPTOR ANTAGONISTS
    Winrow, C. J.
    Doran, S. M.
    Gotter, A. L.
    Pausch, M. H.
    Kuduk, S. D.
    Uslaner, J.
    Carroll, S. S.
    Smith, S.
    Coleman, P. J.
    Renger, J. J.
    SLEEP, 2011, 34 : A5 - A5
  • [46] Dual orexin receptor antagonists - promising agents in the treatment of sleep disorders
    Palasz, Artur
    Lapray, Damien
    Peyron, Christelle
    Rojczyk-Golebiewska, Ewa
    Skowronek, Rafal
    Markowski, Grzegorz
    Czajkowska, Beata
    Krzystanek, Marek
    Wiaderkiewicz, Ryszard
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 (01): : 157 - 168
  • [47] Dual Orexin Receptor Antagonists (DORAs) as an Adjunct Treatment for Smoking Cessation
    Hamidovic, Ajna
    CNS DRUGS, 2022, 36 (05) : 411 - 417
  • [48] Dual Orexin Receptor Antagonists (DORAs) as an Adjunct Treatment for Smoking Cessation
    Ajna Hamidovic
    CNS Drugs, 2022, 36 : 411 - 417
  • [49] Investigation of orexin-2 selective receptor antagonists: Structural modifications resulting in dual orexin receptor antagonists
    Skudlarek, Jason W.
    DiMarco, Christina N.
    Babaoglu, Kerim
    Roecker, Anthony J.
    Bruno, Joseph G.
    Pausch, Mark A.
    O'Brien, Julie A.
    Cabalu, Tamara D.
    Stevens, Joanne
    Brunner, Joseph
    Tannenbaum, Pamela L.
    Wuelfing, W. Peter
    Garson, Susan L.
    Fox, Steven V.
    Savitz, Alan T.
    Harrell, Charles M.
    Gotter, Anthony L.
    Winrow, Christopher J.
    Renger, John J.
    Kuduk, Scott D.
    Coleman, Paul J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (06) : 1364 - 1370
  • [50] Nonclinical pharmacology of daridorexant: a new dual orexin receptor antagonist for the treatment of insomnia
    Roch, Catherine
    Bergamini, Giorgio
    Steiner, Michel A.
    Clozel, Martine
    PSYCHOPHARMACOLOGY, 2021, 238 (10) : 2693 - 2708
12345